AP-70

N/A

Report date: 2022/03/16 09:39:51

Base Information

Drug NameAP-70

Drug Alias NameAP-70

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionAnti-Cluster of differentiation 47

TargetsCluster of differentiation 47

Therapy Area/IndicationsSolid tumoursLymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAprogen

China Registration ClassN/A

Active CompaniesAprogen

Inactive CompaniesN/A

Active IndicationsSolid tumoursLymphoma

Inactive IndicationsN/A

ATC CodeN/A